by | Jun 14, 2026 | Uncategorized
CDC respiratory surveillance updated June 12, 2026 confirms parainfluenza virus (PIV) is elevated nationally. PIV is the leading cause of croup in young children. Summer camp and daycare season is peak exposure time. Here is what parents need to recognize — and when...
by | Jun 14, 2026 | Uncategorized
Active CDC travel notices cover chikungunya outbreaks in Suriname (Feb 2026), Mayotte (March 2026), and French Guiana (June 4, 2026). The FDA-approved Ixchiq vaccine is available but underused. Here is everything summer travelers to the Caribbean and Indian Ocean need...
by | Jun 14, 2026 | Uncategorized
The CDC issued a new Level 2 Travel Health Notice for malaria in Yemen on June 11, 2026, as cases spread into previously low-risk areas. WHO EMRO confirmed 1.44 million cases tested in 2025. Yemen’s malaria is almost exclusively Plasmodium falciparum — the...
by | Jun 13, 2026 | Uncategorized
FDA approved Zaynich (cefepime and zidebactam) on May 29, 2026 for complicated urinary tract infections caused by drug-resistant Gram-negative pathogens. ENHANCE-1 Phase 3 trial showed superiority to meropenem at test of cure. Here is how it works and who...
by | Jun 13, 2026 | Uncategorized
CDC surveillance data (updated June 2026): 463 meningococcal disease cases in 2025 — the second-highest annual count since 2014. The dominant ST-1466 strain is drug resistant and disproportionately kills Black adults ages 30–60 and people with HIV. Here is the full...
Recent Comments